Related Experiment Video
Updated: Jul 7, 2026
10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.4K
[New drugs for small animals in 2024]
Christin Jana Kamutzki1, Ilka Ute Emmerich1
1Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät, Universität Leipzig.
Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere
|April 15, 2025
Summary
In 2024, new veterinary drugs for small animals launched in Germany include treatments for ulcers, anxiety, and diabetes. A new vaccine for Rabbit Hemorrhagic Disease Virus was also approved.
Area of Science:
- Veterinary Pharmacology
- Animal Health
- Drug Development
Context:
- The German veterinary market saw significant new product launches in 2024.
- Focus was on novel pharmaceutical agents for small animal species.
- Existing drugs were also introduced in new formulations.
Purpose:
- To report on the novel pharmaceutical agents and vaccines introduced in the German market for small animals in 2024.
- To highlight new active substances, dosage forms, and combination products.
- To document advancements in veterinary medicine for companion animals.
Summary:
- Three novel agents were introduced: ranitidine (histamine H2-receptor antagonist) for gastric ulcers, tasipimidine (alpha-2-adrenoceptor agonist) for anxiety, and velagliflozin (SGLT-2 inhibitor) for diabetes mellitus.
- New dosage forms or combinations included amlodipine, fluralaner, neomycin sulphate + polymyxin B sulphate, and trilostane.
- A new recombinant vaccine for Rabbit Hemorrhagic Disease Virus was approved; no new vaccines for other diseases were noted.
Impact:
- Provides veterinarians and pet owners with updated information on therapeutic options.
- Facilitates informed decisions regarding the treatment of common small animal conditions.
- Highlights the ongoing innovation in veterinary medicinal products for companion animals.
